do glp 1 cause kidney stones WCET 2025: The Impact of GLP-1 Receptor Agonists on Nephrolithiasis Amongst Patients with Obesity: Insights from a Real-World Data Analysis GLP-1 agonists in the treatment
Description
[DOI] [PubMed] [Google Scholar] 124.Pang Y, et al
While these changes may take longer than medication-based weight loss, they dont carry the same medical risks or financial costs
However, 20% of participants discontinued the pemvidutide 2.4 mg due to AE with the most common being nausea and vomiting - the discontinuation rate was 519% with lower doses [74]
Semaglutide, the active ingredient in Ozempic and Wegovy, was originally developed to help people lose 1522% of body weight in clinical trials
Russo GT, De Cosmo S, Viazzi F, et al
